Polycythemia Vera (PV) – MPN Research Foundation
Skip to content
MPN Research Foundation
Facebook-f
Twitter
Instagram
Search for...
Menu
UNDERSTANDING MPNS
Primary Myelofibrosis (MF)
Essential Thrombocythemia (ET)
Polycythemia Vera (PV)
Glossary
ABOUT MPNRF
Our Mission and History
Board of Directors
MPNRF Team
Scientific Advisory Board
Our Research Impact
News & Articles
Newsletters
Our Partners
LIVING WITH…
MPN Clinical Trials
Find Support
Just Diagnosed
30 Facts about MPNs
Patient Bill of Rights
Patient Stories
Treatments
MAKE AN IMPACT
Make a Donation
Other Ways to Give
Create Your Own Fundraiser
MPN Clinical Trials
RESEARCH
Our Research Impact
2022 Thrive Initiative
MPN Interferon Initiative
The MPN Challenge
MPN Science Reports
Annual MPN Roundtable
Patient-Focused Drug Development
For Researchers
Apply For Funding
DONATE
SUBSCRIBE
Polycythemia Vera (PV)
Polycythemia Vera (PV)
PTG-300
by
MPNRF
March 11, 2021
CPAP Treatment
by
MPNRF
March 11, 2021
Vactosertib
by
MPNRF
March 11, 2021
PRT543
by
MPNRF
March 11, 2021
KRT-232 vs Ruxolitinib
by
MPNRF
March 11, 2021
Givinostat
by
MPNRF
March 11, 2021
Ruxolitinib – Ruxo-BEAT trial
by
MPNRF
March 11, 2021
Ruxolitinib + TGR-1202
by
MPNRF
March 11, 2021
PU-H71
by
MPNRF
March 11, 2021
Familial Study of MPDs
by
MPNRF
March 11, 2021
